Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 29

1.

Cell integrins: commonly used receptors for diverse viral pathogens.

Stewart PL, Nemerow GR.

Trends Microbiol. 2007 Nov;15(11):500-7. Epub 2007 Nov 7. Review.

PMID:
17988871
2.

Prognostic significance of pathologic nodal status in patients with resected pancreatic cancer.

House MG, Gönen M, Jarnagin WR, D'Angelica M, DeMatteo RP, Fong Y, Brennan MF, Allen PJ.

J Gastrointest Surg. 2007 Nov;11(11):1549-55. Epub 2007 Sep 4.

PMID:
17786531
3.

Evaluating integrin function in models of angiogenesis and vascular permeability.

Weis SM.

Methods Enzymol. 2007;426:505-28. Review.

PMID:
17697897
4.

Doxorubicin-induced cardiomyopathy from the cardiotoxic mechanisms to management.

Takemura G, Fujiwara H.

Prog Cardiovasc Dis. 2007 Mar-Apr;49(5):330-52. Review.

PMID:
17329180
5.

Imaging of Vx-2 rabbit tumors with alpha(nu)beta3-integrin-targeted 111In nanoparticles.

Hu G, Lijowski M, Zhang H, Partlow KC, Caruthers SD, Kiefer G, Gulyas G, Athey P, Scott MJ, Wickline SA, Lanza GM.

Int J Cancer. 2007 May 1;120(9):1951-7.

6.

Small molecule tyrosine kinase inhibitors in the treatment of solid tumors: an update of recent developments.

Steeghs N, Nortier JW, Gelderblom H.

Ann Surg Oncol. 2007 Feb;14(2):942-53. Epub 2006 Nov 14. Review.

PMID:
17103252
7.

Multivalent effects of RGD peptides obtained by nanoparticle display.

Montet X, Funovics M, Montet-Abou K, Weissleder R, Josephson L.

J Med Chem. 2006 Oct 5;49(20):6087-93.

PMID:
17004722
8.

Extent of lymph node retrieval and pancreatic cancer survival: information from a large US population database.

Schwarz RE, Smith DD.

Ann Surg Oncol. 2006 Sep;13(9):1189-200. Epub 2006 Sep 6.

PMID:
16955385
9.

Remote loading of doxorubicin into liposomes driven by a transmembrane phosphate gradient.

Fritze A, Hens F, Kimpfler A, Schubert R, Peschka-Süss R.

Biochim Biophys Acta. 2006 Oct;1758(10):1633-40. Epub 2006 Jun 14.

10.

Multivalent RGD synthetic peptides as potent alphaVbeta3 integrin ligands.

Garanger E, Boturyn D, Coll JL, Favrot MC, Dumy P.

Org Biomol Chem. 2006 May 21;4(10):1958-65. Epub 2006 Apr 3.

PMID:
16688341
11.

RGD-based strategies for selective delivery of therapeutics and imaging agents to the tumour vasculature.

Temming K, Schiffelers RM, Molema G, Kok RJ.

Drug Resist Updat. 2005 Dec;8(6):381-402. Epub 2005 Nov 23. Review.

PMID:
16309948
12.

Integrin alphavbeta3 is a coreceptor for human cytomegalovirus.

Wang X, Huang DY, Huong SM, Huang ES.

Nat Med. 2005 May;11(5):515-21. Epub 2005 Apr 17.

13.

Autocrine motility factor signaling enhances pancreatic cancer metastasis.

Tsutsumi S, Yanagawa T, Shimura T, Kuwano H, Raz A.

Clin Cancer Res. 2004 Nov 15;10(22):7775-84.

14.

Drug delivery systems: entering the mainstream.

Allen TM, Cullis PR.

Science. 2004 Mar 19;303(5665):1818-22.

PMID:
15031496
15.

Activated Kras and Ink4a/Arf deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma.

Aguirre AJ, Bardeesy N, Sinha M, Lopez L, Tuveson DA, Horner J, Redston MS, DePinho RA.

Genes Dev. 2003 Dec 15;17(24):3112-26. Epub 2003 Dec 17.

16.

Vascular damage and anti-angiogenic effects of tumor vessel-targeted liposomal chemotherapy.

Pastorino F, Brignole C, Marimpietri D, Cilli M, Gambini C, Ribatti D, Longhi R, Allen TM, Corti A, Ponzoni M.

Cancer Res. 2003 Nov 1;63(21):7400-9.

17.

Molecular imaging of angiogenesis in nascent Vx-2 rabbit tumors using a novel alpha(nu)beta3-targeted nanoparticle and 1.5 tesla magnetic resonance imaging.

Winter PM, Caruthers SD, Kassner A, Harris TD, Chinen LK, Allen JS, Lacy EK, Zhang H, Robertson JD, Wickline SA, Lanza GM.

Cancer Res. 2003 Sep 15;63(18):5838-43.

18.

Anti-tumor efficacy of tumor vasculature-targeted liposomal doxorubicin.

Schiffelers RM, Koning GA, ten Hagen TL, Fens MH, Schraa AJ, Janssen AP, Kok RJ, Molema G, Storm G.

J Control Release. 2003 Aug 28;91(1-2):115-22.

PMID:
12932643
19.

Magnetic resonance imaging of the pancreas and pancreatic tumors in a mouse orthotopic model of human cancer.

Grimm J, Potthast A, Wunder A, Moore A.

Int J Cancer. 2003 Sep 20;106(5):806-11.

20.

Tumor regression by targeted gene delivery to the neovasculature.

Hood JD, Bednarski M, Frausto R, Guccione S, Reisfeld RA, Xiang R, Cheresh DA.

Science. 2002 Jun 28;296(5577):2404-7.

Supplemental Content

Support Center